9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc. (NMTR) Stock Overview
Explore 9 Meters Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1M
P/E Ratio
-0.02
EPS (TTM)
$-1.69
ROE
-2.07%
NMTR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of 9 Meters Biopharma, Inc. (NMTR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.